Validation of an RNase H2 activity assay suitable for clinical screening
M. S. Schulz, C. Guenther, R. Behrendt, A. Roers
The paper validates a FRET-based assay for measuring RNase H2 activity in clinical samples, showing it can detect reduced activity in patient lymphocytes.
bioRxiv · Jun 9, 2022 · PreprintImmunology